mepolizumab (Nucala) Report issue

Biologics mAb Orphan Drug FDA Approved FDA First in Class
AACT ChEMBL DrugBank Drug Central Drugs@FDA KEGG MeSH repoDB
Back

Drug Pricing Summary

VA Big4

$20.8725 - $2233.7400

VA FSS

$27.3934 - $2950.0600

AUS PBS

$1269.9414

Drug Product Pricing

Product $/unit Ctry. List Type
Product (units) Manufacturer
mepolizumab 100 mg (INJECTION) $1269.9414 AUS PBS generic
  • Nucala (1)
    		•  GlaxoSmithKline Australia Pty Ltd
    mepolizumab 100 mg / 1 mL (1 mL INJECTION) $20.8725 VA Big4
  • Nucala (100)
    		•  GlaxoSmithKline
    mepolizumab 100 mg / 1 mL (1 mL INJECTION) $27.3934 VA FSS
  • Nucala (100)
    		•  GlaxoSmithKline
    mepolizumab 100 mg / 1 mL (1 mL INJECTION) $1269.9414 AUS PBS generic
  • Nucala (1)
    		•  GlaxoSmithKline Australia Pty Ltd
    mepolizumab 100 mg / 1 mL (1 mL INJECTION) $2231.9900 VA Big4
  • Nucala (1)
    		•  GlaxoSmithKline
    mepolizumab 100 mg / 1 mL (1 mL INJECTION) $2233.7400 VA Big4
  • Nucala (1)
    		•  GlaxoSmithKline
    mepolizumab 100 mg / 1 mL (1 mL INJECTION) $2950.0600 VA FSS
  • Nucala (1)
    		•  GlaxoSmithKline
  • Nucala (1)
    		•  GlaxoSmithKline

    Note: This drug pricing data is preliminary, incomplete, and may contain errors.

    Feedback

    Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

    Report issue